Empagliflozin in Patients With Heart Failure: Efficacy and Safety Concerns Across Kidney Risk Categories
- PMID: 37793754
- DOI: 10.1016/j.jacc.2023.06.052
Empagliflozin in Patients With Heart Failure: Efficacy and Safety Concerns Across Kidney Risk Categories
Comment on
-
Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney Risk Categories.J Am Coll Cardiol. 2023 May 16;81(19):1902-1914. doi: 10.1016/j.jacc.2023.03.390. J Am Coll Cardiol. 2023. PMID: 37164523
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources